Type 1 diabetes

SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study

Lancet Diabetes EndocrinolPublished Observational cohort study

Main finding · T1D incidence, children <15 yearsResult — go to the resultIRR adjusted for age and sex 1.16 CI 1.06–1.25

Authors' conclusion

Children and adolescents diagnosed with type 1 diabetes during the pandemic had a more severe disease at diagnosis. The observed increase in type 1 diabetes incidence during the first 18 months could be a consequence of lockdown and physical distancing rather than a direct effect of SARS-CoV-2 infection.

Study context

Population
Children in Finland younger than 15 years with newly diagnosed T1D; confirmed monogenic diabetes excluded
Participants
785 vs 2,096
Exposure
First 18 months of COVID-19 pandemic vs pre-pandemic reference period
  • Pandemicn = 785
  • Reference periodn = 2,096reference
Outcome
Incidence of T1D (newly diagnosed per 100 000 person-years)
Follow-up
First 18 months of the COVID-19 pandemic
Methodological detailsregistry-based (Finnish Pediatric Diabetes Register)
  • Registry-based (Finnish Pediatric Diabetes Register)

Main finding

T1D incidence, children <15 years

IRR adjusted for age and sex

1.16

CI 1.06–1.25

P = 0.0006

By group

Pandemic

61.0 per 100 000 person-years

CI 56.8–65.4

Reference period

52.3 per 100 000 person-years

CI 50.1–54.6

Pandemicvs Reference period
IRR adjusted for age and sex 1.16 (CI 1.06–1.25); P = 0.0006

As reported in the abstract

Observational data: associations, not effects.

Further findings

Phenotype at diagnosis
P < 0.001
Phenotype at diagnosis
P < 0.001
Phenotype at diagnosis
P < 0.001
Infection-induced SARS-CoV-2 antibodies among pandemic-period diagnoses
0.9% · 5
  • Infection-induced SARS-CoV-2 antibodies among pandemic-period diagnoses: 583 tested

HLA genotype distribution

No significant differences in HLA genotype distribution between the two periods

Original publication

SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study. Lancet Diabetes Endocrinol. Published April 2023. doi:10.1016/s2213-8587(23)00041-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.